Delek Group Ltd. (TLV:DLEKG)

Regulus Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,213	8,717	8,597	6,879	4,516	1,657
Market Cap Growth	17.68%	1.40%	24.96%	52.35%	172.46%	-73.11%
Enterprise Value	32,714	24,866	27,037	25,724	25,163	26,570
Last Close Price	667.80	454.14	396.18	285.60	188.26	73.80
PE Ratio	11.47	6.21	5.40	1.73	3.15	-
Forward PE	6.60	5.92	3.38	2.10	5.46	-
PS Ratio	0.95	0.73	0.70	0.57	0.58	0.26
PB Ratio	0.65	0.47	0.58	0.53	0.87	0.32
P/TBV Ratio	3.06	2.15	1.40	1.30	-	-
P/FCF Ratio	4.72	4.10	2.20	1.31	1.82	0.85
P/OCF Ratio	2.40	1.97	1.38	1.01	1.29	0.52
PEG Ratio	-	2.96	2.96	2.96	2.96	2.96
EV/Sales Ratio	2.54	2.08	2.19	2.15	3.21	4.13
EV/EBITDA Ratio	3.49	3.13	2.97	2.87	4.45	5.38
EV/EBIT Ratio	6.11	5.75	5.37	4.26	5.16	33.76
EV/FCF Ratio	12.65	11.71	6.93	4.89	10.13	13.67
Debt / Equity Ratio	0.82	0.81	0.97	1.31	2.87	3.49
Debt / EBITDA Ratio	1.65	1.86	1.57	1.88	2.62	3.71
Debt / FCF Ratio	5.97	7.09	3.72	3.21	5.99	9.43
Asset Turnover	0.26	0.25	0.28	0.32	0.24	0.16
Inventory Turnover	5.21	6.59	9.09	8.85	8.19	8.62
Quick Ratio	1.00	0.67	0.75	0.61	0.59	0.12
Current Ratio	1.22	1.06	1.14	0.96	0.89	0.58
Return on Equity (ROE)	11.14%	13.84%	17.14%	50.16%	30.43%	-24.87%
Return on Assets (ROA)	6.74%	5.62%	7.24%	10.14%	9.27%	1.21%
Return on Capital (ROIC)	10.40%	8.57%	10.63%	15.17%	13.98%	1.64%
Return on Capital Employed (ROCE)	11.70%	9.80%	13.30%	17.20%	18.40%	3.40%
Earnings Yield	9.38%	16.11%	18.53%	57.81%	31.71%	-109.63%
FCF Yield	21.17%	24.37%	45.37%	76.42%	54.99%	117.30%
Dividend Yield	7.81%	11.33%	12.28%	8.82%	-	-
Payout Ratio	82.10%	66.95%	69.05%	-	-	-
Buyback Yield / Dilution	-2.65%	-1.30%	1.62%	-7.95%	-29.45%	-14.13%
Total Shareholder Return	5.16%	10.03%	13.90%	0.87%	-29.45%	-14.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.